デフォルト表紙
市場調査レポート
商品コード
1074851

感染症サーベイランスソリューションの世界市場予測(~2028年):コンポーネント別、エンドユーザー別、地域別の分析

Infection Surveillance Solutions Market Forecasts to 2028 - Global Analysis By Component (Software, Services), End User (Hospitals, Ambulatory Service Centers, Clinics, Specialty Centers, Academic Institutes), and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
感染症サーベイランスソリューションの世界市場予測(~2028年):コンポーネント別、エンドユーザー別、地域別の分析
出版日: 2022年05月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の感染症サーベイランスソリューションの市場規模は、2021年に5億2,000万米ドルとなり、予測期間中に16.0%のCAGRで成長し、2028年までに14万8,000米ドルに達すると予測されています。

当レポートでは世界の感染症サーベイランスソリューション市場を調査し、市場の促進要因・抑制要因、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 世界の感染症サーベイランスソリューション市場:コンポーネント別

  • ソフトウェア
    • ウェブベース
    • オンプレミス
  • サービス
    • トレーニングとコンサルティング
    • サポートとメンテナンス
    • 実装

第6章 世界の感染症サーベイランスソリューション市場:エンドユーザー別

  • 病院
    • 大規模病院
    • 中規模病院
    • 小規模病院
  • 外来サービスセンター
  • 診療所
  • 専門センター
  • 介護施設
    • 在宅医療機関とホスピス
    • 養護施設
    • 介助付き住宅施設
  • 学術機関

第7章 世界の感染症サーベイランスソリューション市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東・アフリカ

第8章 主な発展

  • 契約、パートナーシップ、コラボレーション、ジョイントベンチャー
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の重要な戦略

第9章 企業プロファイル

  • Baxter International
  • Becton Dickson & Company
  • bioMerieux, Inc.
  • Cerner Corporation
  • DEB Group Ltd.
  • Emerald Health Information Systems Ltd
  • Hygreen Inc.
  • Quantros, Inc.
  • Vecna Technologies, Inc.
  • Vigilanz Corporation
  • Wolters Kluwer N.V.
  • PeraHealth Inc
図表

List of Tables

  • Table 1 Global Infection Surveillance Solutions Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
  • Table 3 Global Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
  • Table 4 Global Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
  • Table 5 Global Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
  • Table 6 Global Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
  • Table 7 Global Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
  • Table 8 Global Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
  • Table 9 Global Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
  • Table 10 Global Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
  • Table 11 Global Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 12 Global Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
  • Table 13 Global Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
  • Table 14 Global Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
  • Table 15 Global Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
  • Table 16 Global Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 17 Global Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
  • Table 18 Global Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
  • Table 19 Global Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
  • Table 20 Global Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
  • Table 21 Global Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
  • Table 22 Global Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
  • Table 23 North America Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
  • Table 24 North America Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
  • Table 25 North America Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
  • Table 26 North America Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
  • Table 27 North America Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
  • Table 28 North America Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
  • Table 29 North America Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
  • Table 30 North America Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
  • Table 31 North America Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
  • Table 32 North America Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
  • Table 33 North America Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 34 North America Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
  • Table 35 North America Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
  • Table 36 North America Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
  • Table 37 North America Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
  • Table 38 North America Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 39 North America Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
  • Table 40 North America Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
  • Table 41 North America Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
  • Table 42 North America Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
  • Table 43 North America Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
  • Table 44 North America Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
  • Table 45 Europe Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
  • Table 46 Europe Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
  • Table 47 Europe Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
  • Table 48 Europe Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
  • Table 49 Europe Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
  • Table 50 Europe Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
  • Table 51 Europe Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
  • Table 52 Europe Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
  • Table 53 Europe Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
  • Table 54 Europe Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
  • Table 55 Europe Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 56 Europe Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
  • Table 57 Europe Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
  • Table 58 Europe Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
  • Table 59 Europe Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
  • Table 60 Europe Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 61 Europe Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
  • Table 62 Europe Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
  • Table 63 Europe Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
  • Table 64 Europe Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
  • Table 65 Europe Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
  • Table 66 Europe Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
  • Table 67 Asia Pacific Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
  • Table 68 Asia Pacific Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
  • Table 69 Asia Pacific Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
  • Table 70 Asia Pacific Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
  • Table 71 Asia Pacific Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
  • Table 72 Asia Pacific Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
  • Table 73 Asia Pacific Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
  • Table 74 Asia Pacific Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
  • Table 75 Asia Pacific Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
  • Table 76 Asia Pacific Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
  • Table 77 Asia Pacific Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 78 Asia Pacific Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
  • Table 79 Asia Pacific Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
  • Table 80 Asia Pacific Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
  • Table 81 Asia Pacific Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
  • Table 82 Asia Pacific Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 83 Asia Pacific Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
  • Table 84 Asia Pacific Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
  • Table 85 Asia Pacific Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
  • Table 86 Asia Pacific Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
  • Table 87 Asia Pacific Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
  • Table 88 Asia Pacific Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
  • Table 89 South America Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
  • Table 90 South America Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
  • Table 91 South America Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
  • Table 92 South America Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
  • Table 93 South America Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
  • Table 94 South America Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
  • Table 95 South America Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
  • Table 96 South America Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
  • Table 97 South America Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
  • Table 98 South America Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
  • Table 99 South America Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 100 South America Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
  • Table 101 South America Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
  • Table 102 South America Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
  • Table 103 South America Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
  • Table 104 South America Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 105 South America Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
  • Table 106 South America Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
  • Table 107 South America Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
  • Table 108 South America Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
  • Table 109 South America Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
  • Table 110 South America Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
  • Table 111 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Country (2020-2028) ($MN)
  • Table 112 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Component (2020-2028) ($MN)
  • Table 113 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Software (2020-2028) ($MN)
  • Table 114 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Web-based (2020-2028) ($MN)
  • Table 115 Middle East & Africa Infection Surveillance Solutions Market Outlook, By On-premise (2020-2028) ($MN)
  • Table 116 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Services (2020-2028) ($MN)
  • Table 117 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Training & Consulting (2020-2028) ($MN)
  • Table 118 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Support & Maintenance (2020-2028) ($MN)
  • Table 119 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Implementation (2020-2028) ($MN)
  • Table 120 Middle East & Africa Infection Surveillance Solutions Market Outlook, By End User (2020-2028) ($MN)
  • Table 121 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 122 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Large Hospitals (2020-2028) ($MN)
  • Table 123 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Medium-sized Hospitals (2020-2028) ($MN)
  • Table 124 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Small Hospitals (2020-2028) ($MN)
  • Table 125 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Ambulatory Service Centers (2020-2028) ($MN)
  • Table 126 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Clinics (2020-2028) ($MN)
  • Table 127 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Specialty Centers (2020-2028) ($MN)
  • Table 128 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Long-term Care Facilities (2020-2028) ($MN)
  • Table 129 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Homecare Agencies & Hospices (2020-2028) ($MN)
  • Table 130 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Nursing Homes (2020-2028) ($MN)
  • Table 131 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Assisted Living Facilities (2020-2028) ($MN)
  • Table 132 Middle East & Africa Infection Surveillance Solutions Market Outlook, By Academic Institutes (2020-2028) ($MN)
目次
Product Code: SMRC21450

According to Stratistics MRC, the Global Infection Surveillance Solutions Market is accounted for $0.52 billion in 2021 and is expected to reach $1.48 billion by 2028 growing at a CAGR of 16.0% during the forecast period. Infection surveillance systems are deployed to identify infection trends, evaluate and take preventive measures to control them. Infection surveillance systems provide healthcare institutions with accurate information on employee and patient health and surgical databases with real-time monitoring. Hospitals and long-term care facilities are the biggest user groups of infection surveillance systems.

Market Dynamics:

Driver:

Growing occurrences of hospital associated infections (HAIs)

Hospital associated infections in a clinical setting, such as urinary tract infection, pneumonia, and surgical site infections are increasing due to contaminated devices and equipment, bed linens and patient clothing and others. This has prompted healthcare professionals and hospitals to adopt infection surveillance systems to identify possible healthcare associated infections in the duration of patient stay in hospitals and to assist in evaluating preventive measures. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sanitized medical devices. The diagnosis of AROs involves data collection of antibiotic susceptibility test results and correlation of this data with geographical and clinical data for patient populations from whom pathogens were isolated, resulting in detecting an epidemic and facilitating necessary formulations.

Restraint:

Improper data management

Inadequate data management leads to insufficient and incorrect data of patient's medical history and care, which results in inappropriate inferences in surveillance systems. This might lead to difficulty in timely processing of patient data and their surgical history, and this is a factor expected to adversely affect growth of the infection surveillance market globally to a certain extent over the next few years. Increasing volume of data for analysis from different sources such as Enterprise Risk Management (ERM) and HR software along with changing regulatory requirements to calculate and analyze data decreases the efficiency of infection surveillance systems to accurately identify potential infections in patients.

Opportunity:

Growing advancement in IT infrastructure

Rising capacity of IT systems to perform analytic processing coupled with technological advancements in IT systems is aiding in developing analytical and infection surveillance solutions for application in the healthcare industry. These solutions include usage of algorithms with electronic medical records, specialized data mining software, and fully automated HAI surveillance by employing clinical support based knowledge that helps in identification of certain clinical terms. Various developments in surveillance solutions is making it simpler for health and clinical setting staff to better understand surveillance software and its usage, which results in creating a skilled workforce in the healthcare industry.

Threat:

High interoperability costs

The cost of deployment and interoperability of software solutions is considerably high. The small healthcare organizations struggle to implement internet connectivity to utilize healthcare IT solutions. This is mainly due to difficulties in implementing multiple networks with health setups, a lack of wireless connectivity options, and the need to install subsequent myriads of security layers to avoid data breaches. Infection surveillance software is high priced. And most systems need to be customized with respect to the requirements of healthcare facilities. In addition, support and maintenance services, which include modification and upgrading software as per the changing user requirements, represent a recurring expenditure, which accounts for a large share of the total cost of ownership.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is estimated to have a lucrative growth owing to the large patient volume, the increasing incidence of HAIs, and the increasing cases of SSIs. The COVID-19 pandemic has also increased the adoption of infection surveillance solutions in hospitals. The enhanced capacity of IT systems in the analytics is benefiting the development of the market. Hospitals have emerged as the leading end-user in these locations owing to their high adoption rate to maintain electronic healthcare records and managing the real-time pharmacy.

The services segment is expected to have the highest CAGR during the forecast period

The services segment is anticipated to witness the fastest CAGR growth during the forecast period due to the rising demand for product support and maintenance services sub segment. The product support and maintenance services take care of interoperability and software complexity issues. These services ensure that clients (healthcare providers) obtain access to the vendor company's technical knowledge base and acquire application management skills. These factors are driving the growth of the product support and maintenance services segment.

Region with highest share:

Europe is projected to hold the largest market share during the forecast period owing to the high adaption rate of these surveillance systems, encouraged by the governing authorities in the region. Established players are investing in developing economies to strengthen their regional presence. In addition, the growth of the geriatric population has led to an increase in the incidence of serious diseases, which increases the demand for better sanitation facilities, resulting in increased measures to ensure sanitation in the surrounding area, thus increasing the need for infection control in the upcoming years.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period due to growing R&D activities in the medical sciences. Particularly in the United States of America Health and Human Services (HHS), which is governed by the cabinet-level department of the US federal government is very liberal in funding and maintaining the technological research in medical sciences. Moreover, in the United States, increasing healthcare costs are prompting the individual hospitals to move, or merge with independent healthcare groups to form larger healthcare systems that can broaden their service reach, leverage economies of scale, and also can withstand rising regulatory pressures from the recent government.

Key players in the market

Some of the key players profiled in the Infection Surveillance Solutions Market include Baxter International, Becton Dickson & Company, bioMerieux, Inc., Cerner Corporation, DEB Group Ltd., Emerald Health Information Systems Ltd, Hygreen Inc., Quantros, Inc., Vecna Technologies, Inc., Vigilanz Corporation, Wolters Kluwer N.V., and PeraHealth Inc.

Key Developments:

In June 2021, bioMerieux SA has launched EPISEQ® SARS-COV-2, a genomic software solution to support microbiology labs in identification and reporting from raw sequencing data related to SARS-CoV-2 variants. EPISEQ® SARS-COV-2 is compatible with three major sequencing platforms (Illumina, Oxford Nanopore, Thermo Fisher) and easy to use by any microbiology lab without bioinformatics knowledge or computing resources.

In August 2020, Cerner Corporation collaborated with Xealth, to help health systems choose, manage, and deploy digital tools and applications while offering clinicians access to remote monitoring and more direct engagement with patients.

Components Covered:

  • Software
  • Services

End Users Covered:

  • Hospitals
  • Ambulatory Service Centers
  • Clinics
  • Specialty Centers
  • Long-term Care Facilities
  • Academic Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infection Surveillance Solutions Market, By Component

  • 5.1 Introduction
  • 5.2 Software
    • 5.2.1 Web-based
    • 5.2.2 On-premise
  • 5.3 Services
    • 5.3.1 Training & Consulting
    • 5.3.2 Support & Maintenance
    • 5.3.3 Implementation

6 Global Infection Surveillance Solutions Market, By End User

  • 6.1 Introduction
  • 6.2 Hospitals
    • 6.2.1 Large Hospitals
    • 6.2.2 Medium-sized Hospitals
    • 6.2.3 Small Hospitals
  • 6.3 Ambulatory Service Centers
  • 6.4 Clinics
  • 6.5 Specialty Centers
  • 6.6 Long-term Care Facilities
    • 6.6.1 Homecare Agencies & Hospices
    • 6.6.2 Nursing Homes
    • 6.6.3 Assisted Living Facilities
  • 6.7 Academic Institutes

7 Global Infection Surveillance Solutions Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Baxter International
  • 9.2 Becton Dickson & Company
  • 9.3 bioMerieux, Inc.
  • 9.4 Cerner Corporation
  • 9.5 DEB Group Ltd.
  • 9.6 Emerald Health Information Systems Ltd
  • 9.7 Hygreen Inc.
  • 9.8 Quantros, Inc.
  • 9.9 Vecna Technologies, Inc.
  • 9.10 Vigilanz Corporation
  • 9.11 Wolters Kluwer N.V.
  • 9.12 PeraHealth Inc